No-ozone cold plasma induces apoptosis in human neuroblastoma cell line via increased intracellular reactive oxygen species (ROS)

BMC Complement Med Ther. 2024 Jan 20;24(1):46. doi: 10.1186/s12906-023-04313-0.

Abstract

Background: This study aimed to evaluate the effect of argon-based No-ozone Cold Plasma (NCP) on neuroblastoma cancer cell apoptosis.

Methods: Experiments were performed with SK-N-SH and HS 68. Cell cultures were treated with NCP for 1, 3, and 5 min. NCP was applied using three different strategies: direct NCP application to cell cultures, to only media, and to only cells. Evaluation of cell viability and the level of the reactive oxygen species (ROS) was performed. N-acetyl-L-cysteine (NAC) was also used to antagonize intracellular ROS. Cleaved caspase 3, PARP, aquaporin (AQP) 3 and 8 were detected.

Results: NCP induced a gradual decrease in the SK-N-SH cell viability. In contrast, the viability of HS 68 cells did not change. SK-N-SH cells viability was reduced the most when the only media-NCP application strategy was employed. Intracellular ROS levels were significantly increased with time. Cleaved caspase 3 and PARP were increased at 6 h after NCP application. SK-N-SH cells remained viable with NAC after NCP application. AQP 3 and 8 were over-expressed in SK-N-SH cells.

Conclusion: These findings demonstrate the anti-cancer effect of NCP on neuroblastoma cells. NCP enhanced the selective apoptosis of neuroblastoma cells due to the increased intracellular ROS.

Keywords: Anti-cancer effect; Neuroblastoma; No-ozone cold plasma; Plasma activated medium.

MeSH terms

  • Acetylcysteine / pharmacology
  • Acetylcysteine / therapeutic use
  • Apoptosis
  • Caspase 3 / metabolism
  • Cell Line, Tumor
  • Humans
  • Neuroblastoma* / drug therapy
  • Neuroblastoma* / metabolism
  • Ozone* / pharmacology
  • Ozone* / therapeutic use
  • Plasma Gases* / pharmacology
  • Plasma Gases* / therapeutic use
  • Poly(ADP-ribose) Polymerase Inhibitors / pharmacology
  • Poly(ADP-ribose) Polymerase Inhibitors / therapeutic use
  • Reactive Oxygen Species / metabolism

Substances

  • Reactive Oxygen Species
  • Caspase 3
  • Plasma Gases
  • Ozone
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Acetylcysteine